✦ LIBER ✦

11 Response to Infliximab Treatment in Crohn’s Disease is Correlated with Increased Soluble IL-15Rα Serum Levels

✍ Scribed by Gregory Bouchaud; Erwan Mortier; Arnaud Bourreille; Ariane Plet; Yannick Jacques

Book ID: 116397903
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 48 KB
Volume: 39
Category: Article
ISSN: 1043-4666
DOI: 10.1016/j.cyto.2007.07.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sa1231 Elevated Serum IL-17 Levels in Cr

Sa1231 Elevated Serum IL-17 Levels in Crohn's Disease Correlate With Disease Activity but Do Not Predict Response to Infliximab

✍ Abhyankar, Anita; Ham, Maggie; Bai, Aiping; Cheifetz, Adam S.; Robson, Simon C.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 222 KB

Linking genetic susceptibility to Crohn'

Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL-22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status

✍ Silke Schmechel; Astrid Konrad; Julia Diegelmann; Jürgen Glas; Martin Wetzke; Ek 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB 👁 1 views

## Background: We analyzed the influence of Crohn's disease (CD)associated IL23R gene variants on IL-22 that is expressed in IL-23Rϩ Th17 cells. Methods: IL-22 serum levels were measured in 242 CD patients and in 31 healthy controls. Subanalyses included serum levels of IL-6, TNF-␣, IL-17A, IL-17

High serum tumor necrosis factor-α level

High serum tumor necrosis factor-α levels are associated with lack of response to infliximab in fistulizing Crohn’s disease

✍ Jesús Martı́nez-Borra; Carlos López-Larrea; Segundo González; Dolores Fuentes; A 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 102 KB